Literature DB >> 24452816

Hippocampus sparing in whole-brain radiotherapy. A review.

F Oskan1, U Ganswindt, S B Schwarz, F Manapov, C Belka, M Niyazi.   

Abstract

Radiation treatment techniques for whole-brain radiation therapy (WBRT) have not changed significantly since development of the procedure. However, the recent development of novel techniques such as intensity-modulated radiation therapy (IMRT), volumetric-modulated arc therapy (VMAT) and helical tomotherapy, as well as an increasing body of evidence concerning neural stem cells (NSCs) have altered the conventional WBRT treatment paradigm. In this regard, hippocampus-sparing WBRT is a novel technique that aims to spare critical hippocampus regions without compromising tumour control. Published data on this new technique are limited to planning and feasibility studies; data on patient outcome are still lacking. However, several prospective trials to analyse the feasibility of this technique and to document clinical outcome in terms of reduced neurotoxicity are ongoing.

Entities:  

Mesh:

Year:  2014        PMID: 24452816     DOI: 10.1007/s00066-013-0518-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  36 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma.

Authors:  Malin Blomstrand; N Patrik Brodin; Per Munck Af Rosenschöld; Ivan R Vogelius; Gaspar Sánchez Merino; Anne Kiil-Berthlesen; Klas Blomgren; Birgitta Lannering; Søren M Bentzen; Thomas Björk-Eriksson
Journal:  Neuro Oncol       Date:  2012-05-17       Impact factor: 12.300

3.  Feasibility of reducing the irradiation dose in regions of active neurogenesis for prophylactic cranial irradiation in patients with small-cell lung cancer.

Authors:  R Tarnawski; L Michalecki; S Blamek; L Hawrylewicz; T Piotrowski; K Slosarek; R Kulik; B Bobek-Billewicz
Journal:  Neoplasma       Date:  2011       Impact factor: 2.575

4.  Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933.

Authors:  Vinai Gondi; Wolfgang A Tome; James Marsh; Aaron Struck; Amol Ghia; Julius V Turian; Søren M Bentzen; John S Kuo; Deepak Khuntia; Minesh P Mehta
Journal:  Radiother Oncol       Date:  2010-04-12       Impact factor: 6.280

5.  Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.

Authors:  Alexander Sun; Kyounghwa Bae; Elizabeth M Gore; Benjamin Movsas; Stuart J Wong; Christina A Meyers; James A Bonner; Steven E Schild; Laurie E Gaspar; Jeffery A Bogart; Maria Werner-Wasik; Hak Choy
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

6.  Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis.

Authors:  D Rades; J D Kueter; J Gliemroth; T Veninga; A Pluemer; S E Schild
Journal:  Strahlenther Onkol       Date:  2012-01-12       Impact factor: 3.621

7.  Physics strategies for sparing neural stem cells during whole-brain radiation treatments.

Authors:  Neil Kirby; Cynthia Chuang; Jean Pouliot; Andrew Hwang; Igor J Barani
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

Review 8.  Treatment of brain metastases: review of phase III randomized controlled trials.

Authors:  Silvia Scoccianti; Umberto Ricardi
Journal:  Radiother Oncol       Date:  2011-10-11       Impact factor: 6.280

9.  Self-reported cognitive outcomes in patients with brain metastases before and after radiation therapy.

Authors:  Ansa Maer Cole; Angela Scherwath; Gundula Ernst; Heinrich Lanfermann; Michael Bremer; Diana Steinmann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-09-21       Impact factor: 7.038

10.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

View more
  20 in total

1.  Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.

Authors:  N Goerig; S Semrau; B Frey; K Korn; B Fleckenstein; K Überla; A Dörfler; F Putz; U S Gaipl; R Fietkau
Journal:  Strahlenther Onkol       Date:  2016-05-31       Impact factor: 3.621

2.  Early volume reduction of the hippocampus after whole-brain radiation therapy: an automated brain structure segmentation study.

Authors:  Yohei Takeshita; Keita Watanabe; Shingo Kakeda; Toshihiko Hamamura; Koichiro Sugimoto; Hiromi Masaki; Issei Ueda; Natsuki Igata; Takayuki Ohguri; Yukunori Korogi
Journal:  Jpn J Radiol       Date:  2019-10-29       Impact factor: 2.374

3.  A prospective study on neurocognitive effects after primary radiotherapy in high-grade glioma patients.

Authors:  Raphael Bodensohn; Stefanie Corradini; Ute Ganswindt; Jan Hofmaier; Oliver Schnell; Claus Belka; Maximilian Niyazi
Journal:  Int J Clin Oncol       Date:  2015-12-22       Impact factor: 3.402

Review 4.  Recent advances in radiation oncology: intensity-modulated radiotherapy, a clinical perspective.

Authors:  Katsumasa Nakamura; Tomonari Sasaki; Saiji Ohga; Tadamasa Yoshitake; Kotaro Terashima; Kaori Asai; Keiji Matsumoto; Yoshiyuki Shioyama; Hiroshi Honda
Journal:  Int J Clin Oncol       Date:  2014-07-02       Impact factor: 3.402

5.  Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.

Authors:  Oliver Oehlke; David Wucherpfennig; Franziska Fels; Lars Frings; Karl Egger; Astrid Weyerbrock; Vesna Prokic; Carsten Nieder; Anca-Ligia Grosu
Journal:  Strahlenther Onkol       Date:  2015-01-16       Impact factor: 3.621

6.  Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial.

Authors:  Raphael Bodensohn; Anna-Lena Kaempfel; Daniel Felix Fleischmann; Indrawati Hadi; Jan Hofmaier; Sylvia Garny; Michael Reiner; Robert Forbrig; Stefanie Corradini; Niklas Thon; Claus Belka; Maximilian Niyazi
Journal:  Strahlenther Onkol       Date:  2021-04-21       Impact factor: 3.621

7.  Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.

Authors:  Ping-Fang Tsai; Chi-Cheng Yang; Chi-Cheng Chuang; Ting-Yi Huang; Yi-Ming Wu; Ping-Ching Pai; Chen-Kan Tseng; Tung-Ho Wu; Yi-Liang Shen; Shinn-Yn Lin
Journal:  Radiat Oncol       Date:  2015-12-10       Impact factor: 3.481

Review 8.  Stereotactic radiosurgery (SRS) for brain metastases: a systematic review.

Authors:  Carsten Nieder; Anca L Grosu; Laurie E Gaspar
Journal:  Radiat Oncol       Date:  2014-07-12       Impact factor: 3.481

9.  Hippocampal EUD in primarily irradiated glioblastoma patients.

Authors:  Raphael Bodensohn; Matthias Söhn; Ute Ganswindt; Gabriele Schupp; Silke B Nachbichler; Oliver Schnell; Claus Belka; Maximilian Niyazi
Journal:  Radiat Oncol       Date:  2014-12-06       Impact factor: 3.481

Review 10.  The management of brain metastases in non-small cell lung cancer.

Authors:  Scott Owen; Luis Souhami
Journal:  Front Oncol       Date:  2014-09-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.